Cargando…
Pioglitazone Attenuates Cystic Burden in the PCK Rodent Model of Polycystic Kidney Disease
Polycystic kidney disease (PKD) is a genetic disorder characterized by growth of fluid-filled cysts predominately in kidney tubules and liver bile ducts. Currently, the clinical management of PKD is limited to cyst aspiration, surgical resection or organ transplantation. Based on an observation that...
Autores principales: | Blazer-Yost, Bonnie L., Haydon, Julie, Eggleston-Gulyas, Tracy, Chen, Jey-Hsin, Wang, Xiaofang, Gattone, Vincent, Torres, Vicente E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2968120/ https://www.ncbi.nlm.nih.gov/pubmed/21052534 http://dx.doi.org/10.1155/2010/274376 |
Ejemplares similares
-
A randomized phase 1b cross-over study of the safety of low-dose pioglitazone for treatment of autosomal dominant polycystic kidney disease
por: Blazer-Yost, Bonnie L, et al.
Publicado: (2021) -
Effect of Sodium-Glucose Cotransport Inhibition on Polycystic Kidney Disease Progression in PCK Rats
por: Kapoor, Sarika, et al.
Publicado: (2015) -
Metformin does not slow cyst growth in the PCK rat model of polycystic kidney disease
por: Oto, Ozgur A., et al.
Publicado: (2023) -
Collagen-driven remodeling of the intrahepatic duct wall in the PCK rat model of polycystic kidney disease-Caroli syndrome
por: Narayan, Rithika, et al.
Publicado: (2020) -
PPARγ Agonists: Blood Pressure and Edema
por: Blazer-Yost, Bonnie L.
Publicado: (2010)